Mechanism of action of tranexamic acid in bleeding trauma patients: An exploratory analysis of data from the CRASH-2 trial

Critical Care

Volumn 18, Issue 6, 2014, Pages

  Roberts, Ian ^a   Prieto Merino, David ^a   Manno, Daniela ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ARTICLE; BLEEDING; BLOOD TRANSFUSION; CAUSE OF DEATH; CONTROLLED STUDY; DEATH; DRUG EFFECT; DRUG MECHANISM; HUMAN; INJURY; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; EXSANGUINATION; FEMALE; HEMORRHAGE; MALE; MULTIPLE TRAUMA; PROCEDURES; STATISTICS; TRENDS;

ANTIFIBRINOLYTIC AGENTS; CAUSE OF DEATH; EXSANGUINATION; FEMALE; HEMORRHAGE; HUMANS; MALE; MORTALITY; MULTIPLE TRAUMA; STATISTICS AS TOPIC; TRANEXAMIC ACID;

EID: 84927745572     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-014-0685-8     Document Type: Article

References (13)

1. The CRASH-2 Collaborators: Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.Lancet 2010, 376:23-32..
2. The CRASH-2 collaborators: The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial.Lancet 2011, 377:1096-1101..
3. Levy JH. Antifibrinolytic therapy: new data and new concepts. Lancet 2010, 376:3-4. 10.1016/S0140-6736(10)60939-7, 20554318.
4. Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. Arch Surg 2012, 147:113-119. 10.1001/archsurg.2011.287, 22006852.
5. Napolitano LM, Cohen MJ, Cotton BA, Schreiber MA, Moore EE. Tranexamic acid in trauma: how should we use it?. J Trauma Acute Care Surg 2013, 74:1575-1586. 10.1097/TA.0b013e318292cc54, 23694890.
6. Pusateri A, Weiskopf R, Bebarta V, Butler F, Cestero RF, Chaudry IH, Deal V, Dorlac WC, Gerhardt RT, Given MB, Hansen DR, Hoots WK, Klein HG, Macdonald VW, Mattox KL, Michael RA, Mogford J, Montcalm-Smith EA, Niemeyer DM, Prusaczyk WK, Rappold JF, Rassmussen T, Rentas F, Ross J, Thompson C, Tucker LD. Tranexamic acid and trauma: current status and knowledge gaps with recommended research priorities. Shock 2013, 39:121-126. 10.1097/SHK.0b013e318280409a, 23222525.
7. Gruen R, Jacobs I, Reade M. Tranexamic acid and trauma. Med J Aust 2014, 200:255. 10.5694/mja13.00023, 24641138.
8. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H. Standardized bleeding definitions for cardiovascular clinical trials: consensus report from the Bleeding Academic Research Consortium. Circulation 2011, 23:2736-2747. 10.1161/CIRCULATIONAHA.110.009449.
9. Gando S, Sawamura S, Hayakawa M. Trauma, shock, and disseminated intravascular coagulation. Ann Surg 2011, 254:10-19. 10.1097/SLA.0b013e31821221b1, 21368657.
10. Sawamura A, Hayakawa M, Gando S, Kubota N, Sugano M, Wada T, Katabami K. Disseminated intravascular coagulation with a fibrinolytic phenotype at an early phase of trauma predicts mortality. Thromb Res 2009, 1214:608-613. 10.1016/j.thromres.2009.06.034.
11. Levi M, Keller T, van Gorp E, Cate H. Infection and inflammation and the coagulation system. Cardiovasc Res 2003, 60:26-39. 10.1016/S0008-6363(02)00857-X, 14522404.
12. Cesarman-Maus G, Hajjar K. Molecular mechanisms of fibrinolysis. Br J Haematol 2005, 129:307-321. 10.1111/j.1365-2141.2005.05444.x, 15842654.
13. Ker K, Prieto-Merino D, Roberts I. Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss. Br J Surg 2013, 100:1271-1279. 10.1002/bjs.9193, 23839785.